India’s daily cases now third highest in world

NEW DELHI: For the fourth consecutive day, more than 40,000 fresh cases were reported in the country and the steady increase in cases has once again pushed India to become the world’s third-worst affected country in terms of daily cases.

Data compiled by the WHO shows that once again the trio of Brazil, the US and India are leading the world in daily cases. WHO data shows that on March 22, Brazil had reported 79,069 new cases, the highest in the world, followed by the US at 60,228 and India at 46,951. Analysis of daily case data for the past few days shows that India reached the third spot on March 19 and since then it has maintained that position.

India reported 40,622 fresh cases on Monday, with data from Assam yet to arrive till late at night. An analysis of state-wise data shows that the increase in cases was no longer confined to a few states. Despite being a Monday, when cases dip every week, at least nine states reported their highest case count since January or earlier.

Gujarat, for instance, reported 1,640 cases on Monday, the highest ever in the state. Similarly, Monday saw the highest cases this year for Chhattisgarh (1,525), MP (1,348), Delhi (888) and Himachal (200). Tamil Nadu also reported 1,385 cases on Monday, the highest since December 14. Rajasthan reported 602 cases, the highest since January 1. Similarly, UP and Odisha too reported the highest cases since January 10 and January 24, respectively.

So many peaks at the state level suggests that it is highly likely there is a pan-India resurgence of cases.

Deaths too were increasing and the daily toll breached the 200 mark on Sunday.

  • Related Posts

    Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

    The Team Meticulously averted the Risk of Thrombosis, Husband was Donor Delhi/NCR : Doctors at Yashoda Medicity have successfully performed a high-risk kidney transplant in a 28-year-old woman with Antiphospholipid…

    Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

    Avacta, a UK-based clinical stage biotech, is differentiated clinical-stage oncology specialist, increasingly defined by continuing progress with its second-generation pre|CISION tumour-activated Peptide Drug Conjugate (PDC) platform. The lead Gen Two…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

    Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

    Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

    Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

    US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

    US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

    Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

    Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

    Puresta launches EVERQ, AI-powered skin-health platform

    Puresta launches EVERQ, AI-powered skin-health platform

    Stem cell therapy for autism only in approved clinical trials: Centre

    Stem cell therapy for autism only in approved clinical trials: Centre